Advertisement
Longeveron Inc.

Longeveron Inc. (LGVN) Stock Overview

Explore Longeveron Inc.’s financial performance, market position, analyst ratings, and future outlook.

LGVNNASDAQ
HealthcareBiotechnology
$0.69
$0.04(5.29%)
U.S. Market opens in 61h 56m
Advertisement

Longeveron Inc. (LGVN)

Meyka AI Score

Z

Key Financials

Market Cap13.8M
P/E Ratio-0.60
EPS (TTM)$-1.13
ROE-2.02%
Fundamental Analysis

AI Price Forecasts

1 Month$1.22
3 Months$0.58
1 Year Target$0.67

LGVN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Longeveron Inc. (LGVN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 36.81, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.67.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.60 and a market capitalization of 13.8M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.29%
5-Day Change
-5.22%
1-Month Change
-13.69%
3-Month Change
-37.23%
6-Month Change
16.44%
Year-to-Date (YTD) Change
36.46%
1-Year Change
-47.29%
3-Year Change
-97.88%
5-Year Change
-99.09%
All-Time (Max) Change
-99.07%

Contact Information

305 909 0840
1951 NW 7th Avenue, Miami, FL, 33136

Company Facts

250 Employees
IPO DateFeb 12, 2021
CountryUS
Actively Trading

Frequently Asked Questions